Member Info for Sisyphus

Ondine certainly seems to be in a sweet spot as it exploits concerns surrounding increased antibiotic resistance. Results of Steriwave look compelling commercially and fundamentally. Word of mouth is spreading in the health arena quickly and York is currently evaluating for NHS rollout. Could be a sleeping giant if things go well.

Start of the commercial rollout schedule is now happening with batch testing on a commercial platform. Preliminary results should be confirmed and the promised substantial increase in uptake ensuing. Lots of time and R&D spent to get to this stage and a lot of press coverage. Let's hope this is the crest of the peak and it's downhill from here as the potential market for ReZorce is huge. The key factor with ReZorce is the fact that it does not require any Capex by the end user (packager) being totally interchangeable with existing machinery.

The Devils Advocate in my experienced past also dictates a little caution. The RNS also provided Lanstead with a perfect route to sell more shares. Call me sceptical - still waiting and watching for some new news.

Sensible, reasoned explanation of status quo and how to begin to address problem.

I'm not a holder but watching. Good solid update but so many times statements of reassurance are a prelude to a price rise that then triggers an 'unexpected' fundraise. I shall watch the rise today and consider again when the imminent spike has passed. Interesting....at a price.

Sixth sense says this could go to a transatlantic player as it builds scale over there.

Zotefoams looks interesting too at this time. Low valuation yet on cusp of major recycling initiative with global packaging supplier. Too many excellent UK firms at worryingly low MCaps given outlook. Just no institutional or government support. 2p off income tax isn't going solve the underlying problems. Love or hate Boris, at least he kept UK industry in the limelight on the world stagee.

Totally agree. The Conservatives were the custodians of progressive British industry but they have lost control of the drivers that keeps the market buoyant. Solid companies are subject to such over-regulation that the pension funds are just hoarding bonds. It is strangling the UK. All the promises and possibilities afforded by Brexit have been squandered and wasted. Dismal. The chances of a Tory re-election are miniscule. What a complete waste of opportunity.

Agreed. It's actually c 360/374 but that is still far too wide for a company of this size. Come on MMs tighten it.

Sitting on the sidelines here as Lanstead appear to be controlling everything and stifling any rise. It does look like the continued selling pressure is taking it down each week.

Now! Up again from 1908....

Given the underlying quality and security of income here, Halma is seriously lagging in the LSE catch up stakes. Sooner or later Mr Market will wake up to the intrinsic value here and start horizon scanning.

Yes. Next week will give a good perspective on current and near future prospects. As each of the three markets that Hardide services has shown a good upswing we can expect decent traction. There should be a few nice surprises here given the positives highlighted in the interims.

Totally agree.....looking strong after lots of graft winning the contracts.

Https://www.coatingsworld.com/contents/view_online-exclusives/2023-10-03/corrosion-control-is-hardide-coatings-specialty/

This article published last week shows just how Hardide is coming of age as contracts develop. This IP takes years to secure the contracts but the barriers to entry are huge and the rewards are very lucrative and sticky.

Justifiably you have to admit. Purely an observation given the time I've taken researching the IP, prospects and potential given the legislation playing into Hardides strengths. I have certainly been loading up at this derisory MCap and have no intention of either reducing or selling until a realistic value is achieved. That is far higher than this. It's a super little niche player that's aligned with one of the prime suppliers to Airbus recently. Plus numerous other industry heavyweights in wind turbines and industry. Lucrative contracts are tangibly close.

This has to be a 'watch this space' now that Hardide has partnered with Gardner for the coating of Airbus components. Initial orders started June and Airbus wants to replace Hard Chrome plating on guidelines by end 2024. This has a decent ramp up of volume and profit written all over it and Gardner can easily assimilate Hardide ...at a price.

The Hardide-coated components, which are critical to the operation of the flap mechanism, will be used on new-build A320s and as replacement parts for the existing fleet of aircraft as these are maintained. Initial components are expected to be coated in June 2023 with regular monthly volumes thereafter.

........... so we should now have 4 month indicator of volumes. Looking promising.

The Hardide CVD (chemical vapour deposition) nano-structured tungsten/tungsten carbide coating was selected after extensive testing by Airbus and is replacing hard chrome plating (HCP) previously used on these components. This is part of a strategic move by Airbus away from the use of HCP as a result of the REACH regulations, which currently bans the production of HCP in the EU and UK from September 2024.